Early Phase 1 Multiple System Atrophy (MSA) Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

Parkinson DiseaseHealthy AdultMultiple System Atrophy (MSA)

MODAG GmbH13 enrolled1 locationNCT07640555

Recruiting

Early Phase 1

[18F]ACI-15916 PET in α-synucleinopathies

Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)

AC Immune SA46 enrolled1 locationNCT06891703

Recruiting

Early Phase 1

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

Multiple System Atrophy (MSA)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Beijing Tiantan Hospital20 enrolled1 locationNCT06765733